#immunochemotherapy hashtag - Bluesky

From the Labs at Baylor College of Medicine

@bcmfromthelabs.bsky.social

1 month ago

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers - Nature Communications Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immu...

Interested in novel therapies for #TripleNegative #BreastCancer? Drs. D. Pedroza, J Rosen et al have promising new findings. #AntiCSF1R #Immunochemotherapy @natcomms.nature.com #BCMCancerCenter @bcmhouston.bsky.social www.nature.com/articles/s41...

2 1 0 0

Signal Transduction and Targeted Therapy

@sigtrans-sttt.bsky.social

2 months ago

High CD8⁺ #TumorInfiltrating lymphocyte density within #necrotic regions robustly predicts improved event-free survival in #NSCLC after #neoadjuvant #immunochemotherapy, outperforming #radiologic and pathological responses. @upenn.edu

#OpenAccess in #STTT: doi.org/10.1038/s413...

1 0 0 0

Signal Transduction and Targeted Therapy

@sigtrans-sttt.bsky.social

5 months ago

This study identifies #CD8+ nTILs as a strong predictor of event‑free survival in #NSCLC following #neoadjuvant PD‑1 #immunochemotherapy, outperforming radiologic and pathologic responses regardless of PD‑L1 status or #LymphNodeMetastasis. @upenn.edu

#STTT: doi.org/10.1038/s413...

0 0 0 0

Annals of Surgical Oncology

@annsurgoncology.bsky.social

8 months ago

July Issue: Patients with Upper Third of #Esophageal #SquamousCellCarcinoma Have Better Tumor Regression After Neoadjuvant #Immunochemotherapy

rdcu.be/euF3C

0 0 0 0

Respirology Case Reports

@respcasereports.bsky.social

10 months ago

Successful #Immunochemotherapy for Advanced #LungAdenocarcinoma Obstructing the Left Brachiocephalic Vein Complicated by #Chylothorax
onlinelibrary.wiley.com/doi/10.1002/...

0 0 0 0